Therefore, the goal of this study was to assess and analyze the effectiveness of the implemented treatment modality and improvement in health-related quality of life in patients with coxarthrosis after intra-articular administration of PBHSCs CD34+. The gene discussed is CD34; the disease is osteoarthritis, hip.